Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.110
-0.090 (-2.81%)
Jun 2, 2026, 3:04 PM CST
Shenzhen Glory Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,048 | 1,070 | 1,445 | 1,189 | 1,267 | 1,774 |
Other Revenue | 7.07 | 7.07 | 3.69 | 3.62 | 8.27 | 16.52 |
| 1,055 | 1,077 | 1,448 | 1,193 | 1,276 | 1,790 | |
Revenue Growth (YoY) | -27.33% | -25.61% | 21.40% | -6.49% | -28.74% | -21.04% |
Cost of Revenue | 928.82 | 946.36 | 1,195 | 1,038 | 1,060 | 1,470 |
Gross Profit | 126.13 | 130.94 | 253.19 | 155 | 215.55 | 319.9 |
Selling, General & Admin | 139.14 | 140.95 | 145.27 | 153.23 | 157.94 | 170.75 |
Research & Development | 40.2 | 41.56 | 40.78 | 40.07 | 48.18 | 52.37 |
Other Operating Expenses | 27.97 | 28.85 | 22.27 | 19.96 | 18.24 | 22.4 |
Operating Expenses | 314.69 | 294.84 | 236.92 | 266.35 | 351.65 | 251.79 |
Operating Income | -188.56 | -163.9 | 16.27 | -111.34 | -136.1 | 68.11 |
Interest Expense | -15.01 | -15.61 | -5.83 | -2 | -4.44 | -7.22 |
Interest & Investment Income | 22.7 | 22.72 | 13.47 | 17.34 | 17.65 | 31.42 |
Currency Exchange Gain (Loss) | 20.06 | 20.06 | 11.57 | 4.45 | -12.26 | -1.83 |
Other Non Operating Income (Expenses) | -13.37 | -10.67 | -3.02 | -2.5 | -60.37 | -16.87 |
EBT Excluding Unusual Items | -174.17 | -147.4 | 32.46 | -94.05 | -195.53 | 73.61 |
Impairment of Goodwill | -4.04 | -4.04 | - | -10.93 | -56.2 | - |
Gain (Loss) on Sale of Investments | 0.43 | -2.07 | 1.32 | -11.98 | -113.65 | 2.29 |
Gain (Loss) on Sale of Assets | 10.13 | 10.1 | 0.12 | -0.03 | - | -0.03 |
Asset Writedown | -7.91 | -7.91 | -3.2 | -3.01 | -16.86 | -1.23 |
Legal Settlements | -15.67 | -15.67 | -6.32 | -15.25 | -11.75 | -10.74 |
Other Unusual Items | 9.27 | 9.27 | 8.55 | 7.61 | 9.61 | 10.4 |
Pretax Income | -181.84 | -157.58 | 33.6 | -127.64 | -384.37 | 74.29 |
Income Tax Expense | -17.35 | -11.37 | 7.69 | 33.18 | -56.47 | 1.03 |
Earnings From Continuing Operations | -164.49 | -146.21 | 25.91 | -160.82 | -327.9 | 73.26 |
Minority Interest in Earnings | 9.14 | 6.63 | -3.63 | 11.93 | 19.84 | -28.73 |
Net Income | -155.35 | -139.58 | 22.28 | -148.89 | -308.06 | 44.52 |
Net Income to Common | -155.35 | -139.58 | 22.28 | -148.89 | -308.06 | 44.52 |
Net Income Growth | - | - | - | - | - | -72.54% |
Shares Outstanding (Basic) | 825 | 821 | 844 | 845 | 845 | 831 |
Shares Outstanding (Diluted) | 825 | 872 | 884 | 845 | 845 | 870 |
Shares Change (YoY) | -10.60% | -1.34% | 4.64% | 0.03% | -2.86% | 3.89% |
EPS (Basic) | -0.19 | -0.17 | 0.03 | -0.18 | -0.36 | 0.05 |
EPS (Diluted) | -0.19 | -0.17 | 0.03 | -0.18 | -0.36 | 0.05 |
EPS Growth | - | - | - | - | - | -73.57% |
Free Cash Flow | -114.66 | 15 | 38.8 | -24.44 | 39.15 | -187.38 |
Free Cash Flow Per Share | -0.14 | 0.02 | 0.04 | -0.03 | 0.05 | -0.21 |
Dividend Per Share | - | - | 0.008 | - | - | - |
Gross Margin | 11.96% | 12.16% | 17.48% | 12.99% | 16.90% | 17.87% |
Operating Margin | -17.87% | -15.21% | 1.12% | -9.33% | -10.67% | 3.81% |
Profit Margin | -14.73% | -12.96% | 1.54% | -12.48% | -24.15% | 2.49% |
Free Cash Flow Margin | -10.87% | 1.39% | 2.68% | -2.05% | 3.07% | -10.47% |
EBITDA | - | -63.07 | 118.66 | -15.46 | -11.1 | 144.79 |
EBITDA Margin | - | -5.85% | 8.19% | -1.30% | -0.87% | 8.09% |
D&A For EBITDA | - | 100.82 | 102.39 | 95.88 | 125 | 76.68 |
EBIT | -188.56 | -163.9 | 16.27 | -111.34 | -136.1 | 68.11 |
EBIT Margin | -17.87% | -15.21% | 1.12% | -9.33% | -10.67% | 3.81% |
Effective Tax Rate | - | - | 22.89% | - | - | 1.39% |
Revenue as Reported | 1,055 | 1,077 | 1,448 | 1,193 | 1,276 | 1,790 |
Advertising Expenses | - | 0.35 | 0.75 | 1.66 | 0.37 | 0.24 |